Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis.
Anthony J. Monteforte,Brian Lam,Subhamoy Das,Somshuvra Mukhopadhyay,Catherine Wright,Patricia Martin,Andrew K. Dunn,Aaron B. Baker +7 more
44
TL;DR: It is demonstrated that glypisomes are effective means for enhancing growth factor activity and may improve the response to local angiogenic growth factor therapies for ischemia.
read more
About: This article is published in Biomaterials. The article was published on 01 Jul 2016. and is currently open access. The article focuses on the topics: Therapeutic angiogenesis & Vascular endothelial growth factor A.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Therapeutic strategies for enhancing angiogenesis in wound healing.
TL;DR: This review surveys the creation of new treatments for healing cutaneous wounds through therapeutic angiogenesis and discusses the challenges and advancement that have been made in delivering biologic, pharmaceutical and cell-based therapies as enhancers of wound vascularity and healing.
701
Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing.
Subhamoy Das,Aaron B. Baker +1 more
TL;DR: Recent advances in the development of biomaterials and nanoparticle therapeutics to enhance wound healing are discussed, focusing on the novel cutaneous wound treatments that have undergone significant preclinical development or are currently used in clinical practice.
Advances of hydrogel dressings in diabetic wounds.
TL;DR: Wang et al. as discussed by the authors summarized the advances of hydrogel dressings in diabetic wound treatment, aiming to provide theoretical support and inspiration for the development of diabetic wound dressing.
229
Pathological angiogenesis: mechanisms and therapeutic strategies
TL;DR: In this paper , the authors provide an overview of recent insights into blood vessel development and highlight novel therapeutic strategies that promote or inhibit the process of angiogenesis to stabilize, reverse, or even halt disease progression.
Extracellular Matrix, a Hard Player in Angiogenesis.
TL;DR: The aim of this review is to provide some examples of the complex molecular mechanisms that are elicited by these molecules in promoting or weakening the angiogenic processes.
194
References
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
Cindy L. Grines,Matthew W. Watkins,Greg Helmer,William F. Penny,Jeffrey Brinker,Jonathan D. Marmur,Andrew West,Jeffery J. Rade,Pran Marrott,H. Kirk Hammond,Robert L. Engler +10 more
TL;DR: Angiogenic gene transfer with Ad5-FGF4 shows promise as a new therapeutic approach to the treatment of angina pectoris and it appears to be safe.
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.
TL;DR: Enhanced understanding of the regulation of PG metabolism and the involvement of PGs in cancer may offer a novel approach to cancer therapy by targeting the tumor microenvironment.
413
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
Jörg Kleeff,Toshiyuki Ishiwata,Asli Kumbasar,Asli Kumbasar,Helmut Friess,Markus W. Büchler,Arthur D. Lander,Murray Korc +7 more
TL;DR: It is proposed that glypican-1 plays an essential role in the responses of pancreatic cancer cells to certain mitogenic stimuli, that it is relatively unique in relation to other HSPGs, and that its expression by pancreaticcancer cells may be of importance in the pathobiology of this disorder.
Rab11 is required for trans-golgi network-to-plasma membrane transport and a preferential target for GDP dissociation inhibitor.
TL;DR: Analysis of rab11 function in exocytic transport shows that functional rab11 is critical for the export of a basolateral marker but not an apical marker from the trans-Golgi network and pinpoint rab11 as a sensitive target for inhibition by excess GDI.
396
Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor.
TL;DR: The purpose of this study was to evaluate the effects of exogenous recombinant basic fibroblast growth factor (bFGF) on angiogenesis in severely ischemic tissue beds and found that there were no significant differences in baseline TcPO2 among the three groups for both thigh and calf measurements.
360